Search
Sunday 31 May 2015
  • :
  • :

Most Active Stocks In Focus: Exxon Mobil Corporation, (XOM), CenterPoint Energy, (CNP), Teva Pharmaceutical Industries, (TEVA), WisdomTree Investments, (WETF)

On Monday, Shares of Exxon Mobil Corporation (NYSE:XOM), lost -1.68% to $86.78.

Exxon Mobil Corporation, declared that bitumen production began on plan at the $2 billion Cold Lake Nabiye project expansion in northeastern Alberta, Canada.

The expansion is producing about 20,000 barrels per day and volumes are predictable to enhance during the year to peak daily production of 40,000 barrels. Nabiye will access 280 million barrels of recoverable resources during its predictable 30-year lifespan.

ExxonMobil anticipates to enhance production volumes this year by 2 percent to 4.1 million oil-equivalent barrels per day, driven by 7 percent liquids growth. The volume enhance is supported by the ramp up of several projects accomplished in 2014 and the predictable startup of seven new major developments in 2015, counting Hadrian South in the Gulf of Mexico, expansion of the Kearl project in Canada, Banyu Urip in Indonesia and deepwater expansion projects at Erha in Nigeria and Kizomba in Angola.

The project was planned and executed by ExxonMobil Development Company on behalf of the Cold Lake project operator, Imperial Oil Limited, ExxonMobil’s majority owned Canada associate.

Exxon Mobil Corporation explores for and produces crude oil and natural gas in the United States, Canada/South America, Europe, Africa, Asia, and Australia/Oceania. It also manufactures and markets commodity petrochemicals, counting olefins, aromatics, polyethylene and polypropylene plastics, and specialty products; and transports and sells crude oil, natural gas, and petroleum products.

Shares of CenterPoint Energy, Inc. (NYSE:CNP), declined -1.06% to $20.50, during its last trading session.

CenterPoint Energy, stated net income of $131 million, or $0.30 per diluted share, for the first quarter of 2015, contrast with $185 million, or $0.43 per diluted share for the same period of the preceding year. On a guidance basis, for the first quarter 2015, CenterPoint Energy earned 30 cents per diluted share. Utility operations earned 22 cents per diluted share and the equity investment in midstream operations earned 8 cents per diluted share.

Operating income for the first quarter of 2015 was $256 million, contrast with $295 million in the preceding year. Equity income from the company’s investment in midstream operations was $52 million, for the first quarter of 2015, contrast with $91 million in the preceding year.

CenterPoint Energy, Inc. operates as a public utility holding company in the United States. The company’s Electric Transmission & Distribution segment offers electric transmission and distribution services to retail electric providers, municipalities, electric cooperatives, and other distribution companies.

At the end of Monday’s trade, Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA), gained 1.17% to $6.29.

Teva Pharmaceutical, declared that the acquisition of Auspex Pharmaceuticals, Inc. (ASPX) has been accomplished through the successful tender offer for all of the outstanding shares of common stock of Auspex at $101.00 per share in cash, representing total consideration of about $3.2 billion in enterprise value and about $3.5 billion in equity value. The acquisition is predictable to enhance Teva’s revenue and earnings growth profile and strengthen its core central nervous system franchise.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers generic or branded generic medicines; specialized products, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances; and active pharmaceutical ingredients.

Finally, WisdomTree Investments, Inc. (NASDAQ:WETF), ended its last trade with -1.36% gain, and closed at $19.58.

WisdomTree Investments, stated net income of $12.1 million for the first quarter of 2015 or $0.09 per share on a fully diluted basis. This compares to $30.2 million in the first quarter of 2014 (which comprised of a non-recurring tax benefit of $13.7 million) and $9.6 million in the fourth quarter of 2014. Comprised of in the quarter was a loss of $1.8 million, or $0.01 per diluted EPS, associated with the Company`s European listed ETP business, which was attained in April 2014.

WisdomTree CEO and President Jonathan Steinberg said, “We stated a record $13.5 billion in net inflows in the first quarter in the U.S., making WisdomTree one of the fastest-growing companies within the ETF and broader asset administration industry in 2015 to date. WisdomTree`s industry-leading growth underscores our ability to identify and disseminate useful and differentiated investment solutions to an ever-growing ETF market. We also recorded record revenues and pre-tax earnings in the quarter.”

WisdomTree Investments, Inc., through its auxiliaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company also licenses its indexes to third parties for proprietary products, in addition to offers a platform to promote the use of WisdomTree ETFs in 401(k) plans.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *